Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

5.0K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.0K
Mutations01:39

Mutations

83.9K
Overview
83.9K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

45
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
45
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.4K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uniform processing and analysis of IGVF massively parallel reporter assay data with MPRAsnakeflow.

bioRxiv : the preprint server for biology·2025
Same author

varCADD: large sets of standing genetic variation enable genome-wide pathogenicity prediction.

Genome medicine·2025
Same author

Massively parallel jumping assay decodes Alu retrotransposition activity.

Nature communications·2025
Same author

Using individual barcodes to increase quantification power of massively parallel reporter assays.

BMC bioinformatics·2025
Same author

Massively parallel characterization of transcriptional regulatory elements.

Nature·2025
Same author

cfDNA UniFlow: a unified preprocessing pipeline for cell-free DNA data from liquid biopsies.

GigaScience·2024

Related Experiment Video

Updated: Aug 2, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

9.8K

The Regulatory Mendelian Mutation score for GRCh38.

Max Schubach1, Lusiné Nazaretyan1, Martin Kircher1,2

  • 1Exploratory Diagnostic Sciences, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Gigascience
|April 21, 2023
PubMed
Summary

The updated Regulatory Mendelian Mutation (ReMM) score prioritizes noncoding variants for rare Mendelian diseases using the GRCh38 human genome build. A new website and API enhance accessibility for variant pathogenicity assessment.

Keywords:
Mendelian diseaseimbalanced datamachine learningnoncoding scorerare variant analysisvariant predictionweb service

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.8K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

794

Related Experiment Videos

Last Updated: Aug 2, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

9.8K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.8K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

794

Area of Science:

  • Genomics
  • Bioinformatics
  • Human Genetics

Background:

  • Rare Mendelian diseases necessitate prioritizing noncoding variants for diagnosis.
  • Limited tools and annotations exist for the GRCh38 human genome build, hindering variant assessment.
  • The noncoding genome is a growing focus in rare disease research.

Purpose of the Study:

  • To update the Regulatory Mendelian Mutation (ReMM) score for the GRCh38 human genome build.
  • To improve accessibility of variant pathogenicity scores through a website and API.
  • To provide a robust tool for prioritizing noncoding variants in rare Mendelian diseases.

Main Methods:

  • Retraining the ReMM score using features and variants from the GRCh38 genome build.
  • Developing a website and API for variant score lookup and file scoring.
  • Evaluating ReMM score performance on imbalanced datasets.

Main Results:

  • The updated ReMM score demonstrates good performance on imbalanced data, comparable to the GRCh37 version.
  • GRCh38 ReMM scores show high correlation with previous versions, with improved performance due to better feature coverage.
  • The ReMM score outperformed other variation scores for noncoding mutation prioritization in imbalanced datasets.

Conclusions:

  • The ReMM score is a valuable tool for prioritizing noncoding mutations in rare Mendelian diseases.
  • The GRCh38 version and associated web tools enhance the utility and accessibility of ReMM scores.
  • Availability of prescored genome files, UCSC genome browser tracks, and an API facilitates broader research application.